Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.
Clark, L V, Buckland, M, Murphy, G et al. · Clinical and experimental immunology · 2017 · DOI
Quick Summary
This study examined whether people with ME/CFS have abnormal immune protein levels (cytokines) in their blood, especially after physical activity. Researchers compared 24 ME/CFS patients with 21 healthy controls and measured multiple immune markers at rest and after exercise. The study found no significant differences in immune protein levels between the two groups, and no link between post-exertional symptoms and increased cytokine levels.
Why It Matters
This study addresses a long-standing hypothesis that immune dysregulation (specifically elevated cytokines) drives ME/CFS symptoms. If circulating cytokines are not significantly altered in ME/CFS, it redirects research attention toward other potential pathophysiological mechanisms, such as cellular immune dysfunction, neurological factors, or metabolic abnormalities.
Observed Findings
Apparent TGF-β elevation at rest in CFS patients was determined to be an assay artifact from batch variation
No significant differences in TGF-β protein or RNA changes following commuting or aerobic exercise between cases and controls
All other measured cytokine protein and RNA levels were similar between CFS and healthy control groups
No association detected between post-exertional symptom severity and any measured cytokine concentration
No association detected between perceived effort and increased cytokine levels
Inferred Conclusions
Elevated circulating cytokine concentrations are not a consistent feature of ME/CFS
Altered circulating cytokines are unlikely to be central to ME/CFS pathophysiology
Exercise-induced cytokine responses do not appear to distinguish ME/CFS patients from healthy controls
Remaining Questions
Are cytokines elevated in specific tissues or compartments (e.g., cerebrospinal fluid, peripheral blood mononuclear cells) rather than systemic circulation?
Could other immune markers (e.g., cellular immune dysfunction, autoantibodies, complement activation) be more relevant to ME/CFS?
What This Study Does Not Prove
This study does not prove that immune dysfunction is absent in ME/CFS—only that circulating cytokine protein and RNA levels measured in this manner are not prominently altered. It cannot exclude local tissue-based inflammation, intracellular cytokine production, or post-translational modifications. The small sample size and reliance on blood-based measurements limit generalizability to tissue-specific or compartmentalized immune responses.